Surgical treatment and other regional treatments for colorectal cancer liver metastases

Oncologist

Volumn 4, Issue 3, 1999, Pages 197-208

  Yoon, Sam S ^a   Tanabe, Kenneth K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Chemotherapy; Colorectal cancer; Cryosurgery; Hepatectomy; Intra arterial infusion; Liver neoplasm; Radiofrequency ablation

Indexed keywords

DEXAMETHASONE; FLOXURIDINE; FLUOROURACIL; FOLINIC ACID; MELPHALAN; TUMOR NECROSIS FACTOR;

ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CATHETER ABLATION; CLINICAL TRIAL; COLORECTAL CANCER; CRYOSURGERY; HEPATIC ARTERY; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; LIVER METASTASIS; LIVER RESECTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL;

EID: 0033060366     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.4-3-197     Document Type: Article

References (102)

1. Landis SH, Murray T, Bolden S et al. Cancer statistics, 1998. CA Cancer J Clin 1998;48:6-29.
2. Ballantyne GH. Surgical treatment of liver metastases in patients with colorectal cancer. Cancer 1993;71(suppl 12):4252-4266.
3. Foster JH. Treatment of metastatic disease of the liver: a skeptic's view. Semin Liver Dis 1984;4:170-179.
4. Tandan VR, Harmantas A, Gallinger S. Long-term survival after hepatic cryosurgery versus surgical resection for metastatic colorectal carcinoma: a critical review of the literature. Can J Surg 1997;40:175-181.
5. Silen W. Hepatic resection for metastases from colorectal carcinoma is of dubious value. Arch Surg 1989;124:1021-1022.
6. Fong Y, Cohen AM, Fortner JG et al. Liver resection for colorectal metastases. J Clin Oncol 1997;15:938-946.
7. Midis GP, Feig BW. Cancer of the colon, rectum, and anus. In: Feig BW, Berger DH, Fuhrman GM, eds. The M.D. Anderson Surgical Oncology Handbook. Philadelphia: Lippincott Williams & Wilkins, 1999:178-222.
8. Kjeldsen BJ, Kronborg O, Fenger C et al. A prospective randomized study of follow-up after radical surgery for colorectal surgery. Br J Surg 1997;84:666-669.
9. Moertel CG, Fleming TR, Macdonald JS et al. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA 1993;270:943-947.
10. Bruinvels DJ, Stiggelbout AM, Kievit J et al. Follow-up of patients with colorectal cancer. Ann Surg 1994;219:174-182.
11. Pestana C, Reitemeier RJ, Moertel CG et al. The natural history of carcinoma of the colon and rectum. Am J Surg 1964;108:826-829.
12. Jaffe BM, Donegan WL, Watson F et al. Factors influencing survival in patients with untreated hepatic metastases. Surg Gynecol Obstet 1968;127:1-11.
13. Oxley EM, Ellis H. Prognosis of carcinoma of the large bowel in the presence of liver metastases. Br J Surg 1969;56:149-152.
14. Bengmark S, Hafstrom L. The natural history of primary and secondary malignant tumors of the liver. Cancer 1969;23:198-202.
15. Abrams MS, Lerner HJ. Survival of patients at Pennsylvania Hospital with hepatic metastases from carcinoma of the colon and rectum. Dis Colon Rectum 1971;14:431-434.
16. Bengtsson G, Carlsson G, Hafstrom L et al. Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg 1981;141:586-589.
17. Wilson SM, Adson MA. Surgical treatment of hepatic metastases from colorectal cancer. Arch Surg 1976;111:330-333.
18. Wagner JS, Adson MA, Van Heerden JA et al. The natural history of hepatic metastases from colorectal cancer. Ann Surg 1984;199:502-508.
19. Wood CB, Gillis CR, Blumgart LH. A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol 1976;2:285-288.
20. Wanebo HJ, Semoglou C, Attiyeh F et al. Surgical management of patients with primary operable colorectal cancer and synchronous liver metastases. Am J Surg 1978;135:81-85.
21. Povoski SP, Fong Y, Sgouros SC et al. Role of chest CT in patients with negative x-rays referred for hepatic colorectal metastases. Ann Surg Oncol 1998;5:9-15.
22. Evans JT, Dayton MT. Colon, rectum, and anus. In: Lawrence PF, ed. Essentials of General Surgery. Baltimore, MD: Williams & Wilkins, 1992:219-243.
23. Wernecke K, Rummeny EJ, Bongartz G et al. Detection of hepatic masses in patients with carcinoma: comparative sensitivities of sonography, CT and MR imaging. AJR Am J Roentgenol 1991;157:731-739.
24. Haugeberg G, Strohmeyer T, Lierse W et al. The vascularization of liver metastases. J Cancer Res Clin Oncol 1988;114:415-419.
25. Paley MR, Ros PR. Hepatic metastases. Radiol Clin North Am 1998;36:349-363.
26. Soyer P, Bluemke DA, Hruban RH et al. Hepatic metastases from colorectal cancer: detection and false positive findings with helical CT during arterial portography. Radiology 1994;193:71-74.
27. Heiken JP, Weyman PJ, Lee JKT et al. Detection of focal hepatic masses: prospective evaluation with CT, delayed CT, CT during arterial portography, and MR imaging. Radiology 1989;171:47-51.
28. Nelson RC, Chezmar JL, Sugarbaker PH et al. Hepatic tumours: comparison of CT during arterial portography, delayed CT, and MR imaging for preoperative evaluation. Radiology 1989;172:27-34.
29. Nelson RC, Thompson GH, Chezmar JL et al. CT during arterial portography: diagnostic pitfalls. Radiographics 1992;12:705-718.
30. Hamm B, Vogl TJ, Branding G et al. MR imaging with MnDPDP-initial clinical results in 40 patients. Radiology 1992;182:167-174.
31. Ros PR, Freeny PC, Harms SE et al. Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions. Radiology 1995;196:481-488.
32. Seneterre E, Taourel P, Bouvier Y et al. Detection of hepatic metastases: ferumoxide-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. Radiology 1996;200:785-792.
33. Goldenberg DM. Perspectives on oncologic imaging with radiolabeled antibodies. Cancer 1997;80(suppl 12):2431-2435.
34. Moffat FL, Pinsky CM, Hammershaimb L et al. Clinical utility of external immunoscintigraphy with the IMMU-2 technetium-99m Fab' antibody fragment in patients undergoing surgery for carcinoma of the colon and rectum: results of a pivotal, phase III trial. J Clin Oncol 1996;14:2295-2305.
35. Hughes K, Pinsky CM, Petrelli NJ et al. Use of carcinoembryonic antigen radioimmunodetection and computed tomography for predicting the resectability of recurrent colorectal cancer. Ann Surg 1997;226:621-631.
36. Kolecki R, Schirmer B. Intraoperative and laparoscopic ultrasound. Surg Clin North Am 1998;78:251-271.
37. Barbot DJ, Marks JH, Feld RI et al. Improved staging of liver tumors using laparoscopic intraoperative ultrasound. J Surg Oncol 1997;64:63-67.
38. Vauthey JN. Liver imaging: a surgeon's perspective. Radiol Clin North Am 1998;36:445-457.
39. Couinaud C. Le foie. Etudes anatomiques et chirurgicales. Paris: Masson, 1957.
40. Blumgart LH. Liver resection - liver and biliary tumours. In: Blumgart LH, ed. Surgery of the Liver and Biliary Tract, Vol. 1. Edinburgh: Churchill Livingstone, 1994:1495-1535.
41. Iwatsuki S, Sheahan DG, Starzl TE. The changing face of hepatic resection. Curr Probl Surg 1989;26:291-379.
42. Roh MS. Colorectal cancer metastatic to the liver: resection and other techniques. In: Cameron JL, ed. Current Surgical Therapy. St. Louis, MO: Mosby, Inc., 1998:352-355.
43. Schlag P, Hohenberger P, Herfath C. Resection of liver metastases in colorectal cancer - competitive analysis of treatment results in synchronous versus metachronous metastases. Euro J Surg Oncol 1990;16:360-365.
44. Doci R, Gennari L, Bignami P et al. One hundred with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants. Br J Surg 1991;78:797-801.
45. Rosen CB, Nagorney DM, Taswell HF et al. Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg 1992;216:493-505.
46. Gajowski TJ, Iwatsuki S, Madariaga JR et al. Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery 1994;116:703-711.
47. Scheele J, Stang R, Altendorf-Hofmann A et al. Resection of colorectal liver metastases. World J Surg 1995;1995:59-71.
48. Wanebo HJ, Chu QD, Vezeridis MP et al. Patient selection for hepatic resection of colorectal metastases. Arch Surg 1996;131:322-329.
49. Hughes KS, Simon R, Songhorabodi S et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Surgery 1987;103:278-288.
50. Younes RN, Rogatko A, Brennan MF. The influence of intraoperative hypotension and perioperative blood transfusion on disease-free survival in patients with complete resection of colorectal liver metastases. Ann Surg 1991;214:107-113.
51. Griffith KD, Sugarbaker PH, Chang AE. Repeat hepatic resections for colorectal metastases. Surgery 1990;107:101-104.
52. O'Dwyer PJ, O'Riordain DS, Martin EW. Second hepatic resection for metastatic colorectal cancer. Eur J Surg Oncol 1991;17:403-404.
53. Lange JF, Leese T, Castaing D et al. Repeat hepatectomy for recurrent malignant tumors of the liver. Surg Gynecol Obstet 1989;169:119-126.
54. Andersson R, Tranberg KG, Bengmark S. Resection of colorectal liver secondaries: a preliminary report. HPB Surg 1990;2:69-72.
55. Dagradi AD, Mangiante GL, Marchiori LAM et al. Repeat hepatic resection. Int Surg 1987;72.
56. Stone MD, Cady B, Jenkins RL et al. Surgical therapy for recurrent liver metastases from colorectal cancer. Arch Surg 1990;125:718-721.
57. Fortner JG. Recurrence of colorectal cancer after hepatic resection. Am J Surg 1988;155:378-382.
58. Fong Y, Blumgart LH, Cohen A et al. Repeat hepatic resections for metastatic colorectal cancer. Ann Surg 1994;220:657-662.
59. Nordlinger B, Jaeck D, Guiguet M et al. Surgical resection of hepatic metastases: multicentric retrospective study by the French Association of Surgery. In: Nordlinger B, Jaeck D, eds. Treatment of Hepatic Metastases of Colorectal Cancer. New York: Springer-Verlag, 1992:129-146.
60. Fernandez-Trigo V, Shamsa F, Sugarbaker PH et al. Repeat liver resection from colorectal metastasis. Surgery 1995;117:296-304.
61. Goya T, Miyazawa N, Kondo H et al. Surgical resection of pulmonary metastases from colorectal cancer: 10-year follow-up. Cancer 1989;64:1418-1421.
62. Yano T, Hara N, Ichinose Y et al. Results of pulmonary resection of metastatic colorectal cancer and its application. J Thorac Cardiovasc Surg 1993;106:875-879.
63. Gough DB, Donohue JH, Trastek VA et al. Resection of hepatic and pulmonary metastases in patients with colorectal cancer. Br J Surg 1994;81:94-96.
64. Elias D, Lasser P, Rougier P et al. Frequency, technical aspects, results, and indications of major hepatectomy after prolonged intra-arterial hepatic chemotherapy for initially unresectable hepatic tumors. J Am Coll Surg 1995;180:213-219.
65. Fowler WC, Eisenberg BL, Hoffman JP. Hepatic resection following systemic chemotherapy for metastatic colorectal carcinoma. J Surg Oncol 1995;51:122-125.
66. Bismuth H, Adan R, Levi F et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 1996;224:509-522.
67. Whittaker DK. Mechanisms of tissue destruction following cryosurgery. Ann R Coll Surg Engl 1984;66:313-318.
68. Dilley AV, Warlters A, Dy D et al. Hepatic cryotherapy: is portal clamping worth it? Aust N Z J Surg 1991;61:A522.
69. Ravikumar TS, Kane R, Cady B et al. A 5-year study of cryosurgery in the treatment of liver tumors. Arch Surg 1991;126:1520-1523.
70. Ravikumar TS, Steele G, Kane R et al. Experimental and clinical observations on hepatic cryosurgery for colorectal metastases. Cancer Res 1991;51:6323-6327.
71. Kane RA. Ultrasound-guided hepatic cryosurgery for tumour ablation. Sem Interven Radiol 1993;10:132-142.
72. Seifert JK, Junginger T, Morris DL. A collective review of the world literature on hepatic cryotherapy. J R Coll Surg Edin 1998;43:141-154.
73. Weaver ML, Atkinson D, Zemel R. Hepatic cryosurgery in treating colorectal metastases. Cancer 1995;76:210-214.
74. Morris DL, Ross WB, Iqbal J et al. Cryoablation of hepatic malignancy: an evaluation of tumour marker data and survival in 110 patients. GI Cancer 1996;1:247-251.
75. Onik GM, Atkinson D, Zemel R et al. Cryosurgery of liver cancer. Semin Surg Oncol 1993;9:309-317.
76. Goldberg SN, Gazelle GS, Dawson SL et al. Tissue ablation with radiofrequency using multiprobe arrays. Acad Radiol 1995;2:670-674.
77. Livraghi T, Goldberg SN, Monti F et al. Saline-enhanced radio-frequency tissue ablation in the treatment of liver metastases. Radiology 1997;202:205-210.
78. Solbiati L, Ierace T, Goldberg SN et al. Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients. Radiology 1997;202:195-203.
79. Solbiati L, Goldberg SN, Tiziana I et al. Hepatic metastases: percutaneous radio-frequency ablation with cooled-tip electrodes. Radiology 1997;205:367-373.
80. Rossi S, Di Stasi M, Buscarini E et al. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. Am J Roentgenol 1996;167:759-768.
81. Siperstein AE, Rogers SJ, Hansen PD et al. Laparoscopic thermal ablation of hepatic neuroendocrine tumor metastases. Surgery 1997;122:1147-1155.
82. Breedis C, Young G. The blood supply of neoplasms in the liver. Am J Pathol 1954;30:969-985.
83. Collins JM. Pharmacologic rationale for regional drug delivery. J Clin Oncol 1984;2:498-504.
84. Ensminger WD, Rosowsky A, Raso V et al. A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2′-deoxyuridine and 5-fluorouracil. Cancer Res 1978;38:3784-3792.
85. Ensminger WD, Gyves JW. Clinical pharmacology of hepatic arterial chemotherapy. Semin Oncol 1983;10:176-182.
86. Curley SA, Chase JL, Roh MS et al. Technical considerations and complications associated with the placement of 180 implantable hepatic arterial infusion devices. Surgery 1993;114:928-935.
87. Knol JA. Colorectal cancer metastatic to the liver: hepatic arterial infusion chemotherapy. In: Cameron JL, ed. Current Surgical Therapy. St. Louis, MO: Mosby, Inc., 1998:355-361.
88. Kemeny N, Daly J, Reichman B et al. Intrahepatic or systemic infusion of fluorodeoxyuridine in with liver metastases from colorectal carcinoma. Ann Intern Med 1987;107:459-465.
89. Chang AE, Schneider PD, Sugarbaker PH et al. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 1987;206:685-693.
90. Hohn DD, Stagg RJ, Friedman MS et al. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group Trial. J Clin Oncol 1989;7:1646-1654.
91. Wagman LD, Kemeny MM, Leong G et al. A prospective randomized evaluation of the treatment of colorectal cancer metastatic to the liver. J Clin Oncol 1990;8:1885-1893.
92. Martin KJ, O'Connell MJ, Wieand HS et al. Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. Arch Surg 1990;125:1022-1027.
93. Harmantas A, Rotstein LE, Langer B. Regional versus systemic chemotherapy in the treatment of colorectal carcinoma liver metastatic to the liver. Cancer 1996;78:1639-1645.
94. Rougier P, Laplanche A, Huguier M et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal cancer: long term results of a prospective randomized trial. J Clin Oncol 1992;10:1112-1118.
95. Venook AP. Update on hepatic intra-arterial chemotherapy. Oncology 1997;11:947-957.
96. Safi F, Bittner R, Rosher R et al. Regional chemotherapy for hepatic metastases from colorectal carcinoma (continuous intraarterial versus continuous intraarterial/intravenous therapy): results of a controlled clinical trial. Cancer 1989;6:379-387.
97. Stagg RJ, Venook AP, Chase JL et al. Alternating hepatic intra-arterial floxuridine and fluorouracil: a less toxic regimen for treatment of liver metastases from colorectal cancer. J Natl Cancer Inst 1991;83:423-428.
98. Kemeny N, Seiter K, Niedzwiecki D et al. A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic cancer. Cancer 1992;69:327-334.
99. Kemeny N, Seiter K, Conti JA et al. Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal cancer. Cancer 1994;73:1134-1142.
100. Kemeny N, Conti JA, Cohen A et al. Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma. J Clin Oncol 1994;12:2288-2295.
101. Curley SA, Roh MS, Chase JL et al. Adjuvant hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases. Am J Surg 1993;166:743-748.
102. Alexander HR, Bartlett DL, Libutti SK et al. Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver. J Clin Oncol 1998;16:1479-1489.